Which of the following is NOT a brand name included in Part I of the Schedule in Part G of the FDR?

In the context of Saskatchewan Pharmacy Law and the Federal Drug Regulations (FDR), it's essential to understand how drugs are categorized and the significance of brand names versus generic names. Part I of the Schedule in Part G of the FDR lists specific controlled and regulated substances, often accompanied by their brand names.

Lisdexamfetamine is marketed as Vyvanse and falls under controlled substances commonly used for ADHD. Methylphenidate, known as Biphentin, is also listed due to its use in treating ADHD. Dextroamphetamine, marketed as Dexedrine, is another stimulant included in the same category.

However, Phenobarbital, the active ingredient in Phenobarb, is primarily classified as a barbiturate used for seizure management and does not fall into the stimulant category or the same regulations as the other options listed. It may have a different schedule or regulatory classification, which is why it is indicated as not being included in the same group as the others concerning the FDR's Part I Schedule.

This understanding of both the classifications of these drugs and their regulations highlights why Phenobarbital (Phenobarb), despite being a recognized medication, does not belong in that particular part of the Schedule related to stimulants or controlled